Evidence map›Paper›PMID 26651243›Full record

ArticleCell adhesion & migration2015

Cell surface heparan sulfate proteoglycans are involved in the binding of Hsp90α and Hsp90β to the cell plasma membrane.

Anastasiya V Snigireva, Veronika V Vrublevskaya, Vladimir N Afanasyev, Oleg S Morenkov

Open access · goldAbstract read
In one paragraph

Article in Cell adhesion & migration, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Lipophosphoglycan 3 FromBioinformatics and biology insights · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Anastasiya V Snigirevaa Institute of Cell Biophysics; Russian Academy of Sciences ; Pushchino , Russia.
Veronika V Vrublevskayaa Institute of Cell Biophysics; Russian Academy of Sciences ; Pushchino , Russia.
Vladimir N Afanasyeva Institute of Cell Biophysics; Russian Academy of Sciences ; Pushchino , Russia.
Oleg S Morenkova Institute of Cell Biophysics; Russian Academy of Sciences ; Pushchino , Russia.
Institute of Cell Biophysics · RUInstitute of Life Sciences · INRussian Academy of Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular membrane-bound and secreted heat shock protein 90 (Hsp90) is known to be involved in cell motility and invasion. The mechanism of Hsp90 anchoring to the plasma membrane remains obscure. We showed that treatment of human glioblastoma A-172 and fibrosarcoma HT1080 cells with sodium chlorate, heparinase, and heparin causes a prominent loss of 2 Hsp90 cytosolic isoforms, Hsp90α and Hsp90β, from the cell surface and strongly inhibits the binding of exogenous Hsp90 to cells. We revealed that Hsp90α and Hsp90β are partly colocalized with heparan sulfate proteoglycans (HSPGs) on the cell surface and that this colocalization was sensitive to heparin. The results demonstrate that cell surface HSPGs are involved in the binding/anchoring of Hsp90α and Hsp90β to the plasma membrane.

Indexed as

Cell Line, TumorCell MembraneCell MovementFibrosarcomaHeparan SulfateHeparinHSP90 Heat-Shock ProteinsHumansMembrane GlycoproteinsProtein BindingHeparan SulfateHeparinHSP90AA2P protein, humanHSP90AB1 protein, humanHSP90 Heat-Shock ProteinsMembrane Glycoproteinsanchoring and binding to plasma membraneand Hsp90βcell surface-bound Hsp90αcell surface HSPGsextracellular Hsp90human glioblastoma A-172 and fibrosarcoma HT1080 cells

Identifiers

PMID26651243
PMCPMC4955955
OpenAlexW2220713859

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.